Alkem gets two observations from USFDA for St Louis-based formulation plant

The company shall submit to USFDA within the stipulated timeline, a detailed response to close out all the observations associated with this inspection, the drug firm said.

from Industry-Economic Times
Read The Rest:economictimes...